Markets.com Logo
markets.com

NMRD

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    --
  • Previous Close
    --
  • 52 Week Change
    --
  • Day Range
    --
  • 52 Week High/Low
    --
  • Dividend Per Share
    --
  • Market cap
    --
  • EPS
    --
  • Beta
    --
  • Volume
    --

About

NMRD.US represents Nemaura Medical Inc., a medical technology company focused on developing and commercializing non-invasive wearable diagnostic devices and metabolic health solutions. Their primary product is the sugarBEAT® continuous glucose monitoring (CGM) system intended for use by individuals with diabetes and pre-diabetes, as well as for general wellness monitoring. The company also explores other diagnostic applications utilizing its sensor technology. Nemaura Medical is listed on the Nasdaq stock exchange.
markets.com
Micron vs SanDisk: Which Stock Is Better Positioned for AI Growth?

Micron vs SanDisk: Which Stock Is Better Positioned for AI Growth?

Julian Parker|--
AMD vs Intel vs Arm: Which Stock Could Benefit Most From the AI Inference Boom?

AMD vs Intel vs Arm: Which Stock Could Benefit Most From the AI Inference Boom?

Daniel Carter|--
AMD Joins the $1 Trillion Club as AI Demand Lifts Shares: AI Chip Stock Forecast and Outlook

AMD Joins the $1 Trillion Club as AI Demand Lifts Shares: AI Chip Stock Forecast and Outlook

Julian Parker|--
British Pound Short-Term Outlook: Can GBP/USD Hold 1.33 as Fed–BoE Policy Divergence Widens?

British Pound Short-Term Outlook: Can GBP/USD Hold 1.33 as Fed–BoE Policy Divergence Widens?

Julian Parker|--
Stellar XLM Price Prediction 2026, 2027 & 2030: Can XLM Reach $1?

Stellar XLM Price Prediction 2026, 2027 & 2030: Can XLM Reach $1?

Daniel Carter|--

The energy sector remains a hot topic & precious metals

Darius Anucauskas|--
Dollar to Mexican Peso Forecast 2026–2030: Can USD/MXN Break Above 17.50 as the Rate Gap Narrows?

Dollar to Mexican Peso Forecast 2026–2030: Can USD/MXN Break Above 17.50 as the Rate Gap Narrows?

Julian Parker|--

Factors

Company Performance: Positive earnings reports, successful drug trials, and FDA approvals generally drive the stock price up, while negative results can cause it to fall.

Market Sentiment: Overall market conditions and investor confidence in the pharmaceutical sector can significantly impact NMRD.US stock. Broad market downturns often lead to declines, even for healthy companies.

Competition: The emergence of competing drugs or therapies from other companies can negatively affect the projected market share and profitability of NMRD.US's products, impacting the stock price.

Regulatory Environment: Changes in government regulations related to drug pricing, approval processes, or patent laws can have a substantial impact on the pharmaceutical industry, influencing the valuation of companies like NMRD.US.

Clinical Trial Results: Positive data from clinical trials, especially Phase 3 trials, can boost investor confidence and increase the stock price. Conversely, disappointing results or safety concerns can lead to a decline.

Economic Factors: Macroeconomic conditions such as interest rates, inflation, and economic growth can influence investor behavior and impact the valuation of all stocks, including NMRD.US.

Mergers and Acquisitions: Rumors or actual announcements of mergers, acquisitions, or partnerships involving NMRD.US can cause significant price fluctuations as investors speculate on the potential benefits or risks.

Analyst Ratings: Upgrades or downgrades from financial analysts can influence investor perception and trading activity, leading to corresponding changes in the stock price of NMRD.US.

Patent Protection: The strength and duration of patent protection for NMRD.US's drugs are crucial for maintaining market exclusivity and profitability. Patent expirations or challenges can negatively impact the stock.

Drug Pricing and Reimbursement: Decisions by insurance companies and government healthcare programs regarding the pricing and reimbursement of NMRD.US's drugs can significantly affect revenue and profitability, influencing the stock price.

People Also Watch

Latest news

Gold Price Today: Gold Holds Near $4,280 After Strong US PMI Sends Treasury Yields Higher

Gold Price Today: Gold Holds Near $4,280 After Strong US PMI Sends Treasury Yields Higher

Julian Parker|--
McDonald’s Stock Falls Nearly 5% as NEXT Investor Day Raises Turnaround Questions

McDonald’s Stock Falls Nearly 5% as NEXT Investor Day Raises Turnaround Questions

Julian Parker|--
Treasury Yields Spike After Strong US PMI as Nasdaq Falls More Than 1%

Treasury Yields Spike After Strong US PMI as Nasdaq Falls More Than 1%

Julian Parker|--

Latest Education Articles

Risk Management 101

Risk Management 101

Julian Parker|--
Best AI Stocks to Buy Now: 10 Best Performing AI Stocks to Watch in 2026

Best AI Stocks to Buy Now: 10 Best Performing AI Stocks to Watch in 2026

Julian Parker|--
Gold Scalping Strategy: How Scalping XAU/USD Works

Gold Scalping Strategy: How Scalping XAU/USD Works

Julian Parker|--
Recommended Topics
markets.com